Gender and telomere length: systematic review and meta-analysis
- PMID: 24365661
- PMCID: PMC4523138
- DOI: 10.1016/j.exger.2013.12.004
Gender and telomere length: systematic review and meta-analysis
Abstract
Background: It is widely believed that females have longer telomeres than males, although results from studies have been contradictory.
Methods: We carried out a systematic review and meta-analyses to test the hypothesis that in humans, females have longer telomeres than males and that this association becomes stronger with increasing age. Searches were conducted in EMBASE and MEDLINE (by November 2009) and additional datasets were obtained from study investigators. Eligible observational studies measured telomeres for both females and males of any age, had a minimum sample size of 100 and included participants not part of a diseased group. We calculated summary estimates using random-effects meta-analyses. Heterogeneity between studies was investigated using sub-group analysis and meta-regression.
Results: Meta-analyses from 36 cohorts (36,230 participants) showed that on average females had longer telomeres than males (standardised difference in telomere length between females and males 0.090, 95% CI 0.015, 0.166; age-adjusted). There was little evidence that these associations varied by age group (p=1.00) or cell type (p=0.29). However, the size of this difference did vary by measurement methods, with only Southern blot but neither real-time PCR nor Flow-FISH showing a significant difference. This difference was not associated with random measurement error.
Conclusions: Telomere length is longer in females than males, although this difference was not universally found in studies that did not use Southern blot methods. Further research on explanations for the methodological differences is required.
Keywords: Epidemiology; Gender; Measurement methods; Systematic review and meta-analysis; Telomere length.
Copyright © 2013. Published by Elsevier Inc.
Conflict of interest statement
This is an original work, and it has never been published nor is under consideration for publication elsewhere. All the authors have substantially contributed to data collection and manuscript drafting and revision. Peter Lansdorp is a founding shareholder in Repeat Diagnostics, a company specializing in leukocyte telomere length measurements using flow FISH. All other authors have not declared any conflicts of interest.
Figures
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The association between post-traumatic stress disorder and shorter telomere length: A systematic review and meta-analysis.J Affect Disord. 2017 Aug 15;218:322-326. doi: 10.1016/j.jad.2017.03.048. Epub 2017 Mar 27. J Affect Disord. 2017. PMID: 28486180 Review.
-
Change in the telomere length distribution with age in the Japanese population.Mol Cell Biochem. 2007 Oct;304(1-2):353-60. doi: 10.1007/s11010-007-9518-2. Epub 2007 Jun 27. Mol Cell Biochem. 2007. PMID: 17594061
-
Effect of different levels of exercise on telomere length: A systematic review and meta-analysis.J Rehabil Med. 2019 Jul 8;51(7):473-478. doi: 10.2340/16501977-2560. J Rehabil Med. 2019. PMID: 31093683
-
Is COVID-19 severity associated with telomere length? A systematic review and meta-analysis.Virus Genes. 2023 Aug;59(4):489-498. doi: 10.1007/s11262-023-02010-1. Epub 2023 Jun 1. Virus Genes. 2023. PMID: 37261700 Free PMC article. Review.
Cited by
-
The Contribution of Plasma and Brain Vitamin C on Age and Gender-Related Cognitive Differences: A Mini-Review of the Literature.Front Integr Neurosci. 2020 Aug 21;14:47. doi: 10.3389/fnint.2020.00047. eCollection 2020. Front Integr Neurosci. 2020. PMID: 32973470 Free PMC article. Review.
-
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer.Diagnostics (Basel). 2024 Jun 7;14(12):1210. doi: 10.3390/diagnostics14121210. Diagnostics (Basel). 2024. PMID: 38928626 Free PMC article.
-
Racial and Socioeconomic Variation in Genetic Markers of Telomere Length: A Cross-Sectional Study of U.S. Older Adults.EBioMedicine. 2016 Sep;11:296-301. doi: 10.1016/j.ebiom.2016.08.015. Epub 2016 Aug 11. EBioMedicine. 2016. PMID: 27566956 Free PMC article.
-
The epigenetic clock and telomere length are independently associated with chronological age and mortality.Int J Epidemiol. 2018 Feb;45(2):424-432. doi: 10.1093/ije/dyw041. Epub 2016 Apr 13. Int J Epidemiol. 2018. PMID: 27075770 Free PMC article.
-
The Human Blood Transcriptome in a Large Population Cohort and Its Relation to Aging and Health.Front Big Data. 2020 Oct 30;3:548873. doi: 10.3389/fdata.2020.548873. eCollection 2020. Front Big Data. 2020. PMID: 33693414 Free PMC article.
References
-
- Adams J, Martin-Ruiz C, Pearce MS, White M, Parker L, von Zglinicki T. No association between socio-economic status and white blood cell telomere length. Aging Cell. 2007;6:125–128. - PubMed
-
- Aubert G, Baerlocher GM, Vulto I, Poon SS, Lansdorp PM. Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes. PLoS Genet. 2012;8 http://dx.doi.org/10.1371/journal.pgen.1002696. - DOI - PMC - PubMed
-
- Austad SN. Why women live longer than men: sex differences in longevity. Gend Med. 2006;3:79–82. - PubMed
-
- Aviv A. Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med. 2002;80:689–695. - PubMed
-
- Aviv A, Valdes AM, Spector TD. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int J Epidemiol. 2006;35:1424–1429. - PubMed
Publication types
MeSH terms
Grants and funding
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- HL80698/HL/NHLBI NIH HHS/United States
- UL1-RR-024156/RR/NCRR NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- N01HC85086/HL/NHLBI NIH HHS/United States
- MC_UP_A620_1014/MRC_/Medical Research Council/United Kingdom
- N01HC95159/HL/NHLBI NIH HHS/United States
- R01 HL080295/HL/NHLBI NIH HHS/United States
- N01HC85082/HL/NHLBI NIH HHS/United States
- N01HC85083/HL/NHLBI NIH HHS/United States
- HL080295/HL/NHLBI NIH HHS/United States
- N01HC85080/HL/NHLBI NIH HHS/United States
- G0601333/MRC_/Medical Research Council/United Kingdom
- MC_UP_A620_1015/MRC_/Medical Research Council/United Kingdom
- UL1 RR025005/RR/NCRR NIH HHS/United States
- UL1-RR-025005/RR/NCRR NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- N01-HC-95168/HC/NHLBI NIH HHS/United States
- N01HC95169/HL/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- ETM/55/CSO_/Chief Scientist Office/United Kingdom
- MC_UU_12011/2/MRC_/Medical Research Council/United Kingdom
- G0700704/MRC_/Medical Research Council/United Kingdom
- MC_PC_13040/MRC_/Medical Research Council/United Kingdom
- MC_UU_12017/7/MRC_/Medical Research Council/United Kingdom
- MC_UU_12011/1/MRC_/Medical Research Council/United Kingdom
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- R01 HL080698/HL/NHLBI NIH HHS/United States
- N01HC55222/HL/NHLBI NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- MC_UP_A540_1021/MRC_/Medical Research Council/United Kingdom
- N01-HC-95169/HC/NHLBI NIH HHS/United States
- MR/K007017/1/MRC_/Medical Research Council/United Kingdom
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- G0500997/MRC_/Medical Research Council/United Kingdom
- MR/K023209/1/MRC_/Medical Research Council/United Kingdom
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- N01HC85079/HL/NHLBI NIH HHS/United States
- N01-HC-95166/HC/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- AG023629/AG/NIA NIH HHS/United States
- R56 AG023629/AG/NIA NIH HHS/United States
- CZB/4/505/CSO_/Chief Scientist Office/United Kingdom
- SPHSU2/CSO_/Chief Scientist Office/United Kingdom
- MC_U147585824/MRC_/Medical Research Council/United Kingdom
- BB/F019394/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- MC_UU_12017/5/MRC_/Medical Research Council/United Kingdom
- N01-HC-95167/HC/NHLBI NIH HHS/United States
- N01HC85081/HL/NHLBI NIH HHS/United States
- MR/K026992/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical